Neoadjuvant Sunitinib Decreases Inferior Vena Caval Thrombus Size and Is Associated With Improved Oncologic Outcomes: A Multicenter Comparative Analysis.

Charles A Field,Brittney H Cotta,Juan Jimenez,Brian R Lane,Kendrick Yim,Hak J Lee,Stephen T Ryan,Zachary A Hamilton,Sunil Patel, Song Wang,Christopher J Kane,Sumi Dey,Rana R Mckay,Sabrina Noyes,Frederick E Millard,Brian I Rini,Steven C Campbell,Ithaar H Derweesh

Clinical Genitourinary Cancer（2019）

引用 23|浏览41

暂无评分

摘要

Neoadjuvant sunitinib was associated with a reduction in primary tumor and thrombus size as well as improved survival. Further investigation is needed to determine the utility of neoadjuvant sunitinib in RCC with IVC tumor.

查看译文

关键词

Inferior vena cava,Neoadjuvant therapy,Nephrectomy,Renal cell carcinoma,Survival

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要